
Novel Drug Approvals for 2025 | FDA
Nov 3, 2025 · To see the FDA-approved conditions of use [e.g., indication (s), population (s), dosing regimen (s)] for each of these products, please see the most recently approved …
Medical Breakthroughs 2025 | Latest Research & Discoveries
1 day ago · Latest medical breakthroughs 2025 with research findings, new treatments, and healthcare innovations. Medical news, health discoveries, and treatment updates.
FDA News Month in Review: January 2025 - HCPLive
On January 15, 2025, Lilly announced that the FDA approved mirikizumab (Omvoh) for the treatment of adults with moderately to severely active Crohn's disease (CD).
New and notable treatments from 2025 - healthcare-brew.com
Dec 2, 2025 · Pharma New and notable treatments from 2025 From HIV to opioids, 2025 brought solutions to some of the world’s most pressing health issues.
Top FDA Approvals of 2025: Breakthrough Drugs Transforming …
Explore the most impactful FDA drug approvals of 2025, including treatments for cancer, Alzheimer’s, and rare diseases. See how biotech innovation is shaping healthcare.
Mid-year review: notable FDA drug approvals of 2025
Jul 8, 2025 · In this article, we take a look at some of the standout approvals that are poised to make a meaningful impact on patient care. Approval date: January 30, 2025. Journavx …
Top 10 Breakthrough Medicines Approved in 2025
Oct 5, 2025 · With several new drugs approved in 2025, the global medical community is witnessing breakthroughs in oncology, rare diseases, genetic disorders, and pain management.
Breakthrough Treatments | Latest FDA Approvals | Health Pioneer
Discover the latest breakthrough medical treatments, FDA approvals, and clinical trial results. Stay informed about cutting-edge therapies changing healthcare.
Guideline Med Alerts & FDA Approvals - January 2025
Feb 3, 2025 · A compiled list of all the medications approved by the Food and Drug Administration (FDA) during the month of January 2025.
January 2025: Notable Drug Approvals - MPR
Feb 6, 2025 · Some of the notable drug approvals that occurred in January 2025.